Progress toward development of vaccines against melioidosis: A review
- PMID: 20728758
- DOI: 10.1016/j.clinthera.2010.07.020
Progress toward development of vaccines against melioidosis: A review
Abstract
Background: Melioidosis is a serious and often fatal disease that is prevalent in subtropical and tropical climates, primarily in at-risk groups (eg, those with diabetes, alcoholism, or other cause of immunosuppression). Treatment is often unsuccessful, with infection frequently relapsing. Burkholderia pseudomallei, the etiologic agent of melioidosis, is inherently resistant to many antibiotics.
Objective: This article reviews available evidence on the development of vaccines against melioidosis, including live attenuated vaccines, inactivated whole cell vaccines, and recombinant subunit vaccines.
Methods: Web of Science and PubMed (1950-February 2010) were searched for relevant reports using the term Burkholderia pseudomallei alone and combined with live attenuated vaccine, inactivated vaccine, animal models, and immunity. The reference lists of identified articles were reviewed for additional relevant publications.
Results: Studies in murine models suggest that protective immunity against B pseudomallei may be induced by a range of living and nonliving immunogens. The strongest protective immunity was induced by live attenuated immunogens, although concerns about latency make it unlikely that such vaccines will be appropriate for use in humans. Heat-inactivated immunogens have shown promise, and several candidates for subunit vaccines have been tested. However, in all cases, it has been difficult to achieve induction of sterile immunity and protection against airborne infection.
Conclusions: Live attenuated mutants of B pseudomallei have been found to be the most effective immunogens in mice, although it is unlikely that such mutants would be appropriate for a vaccine against melioidosis in humans. The ongoing challenge is to identify nonliving formulations that are able to induce good protective immunity. Both humoral and cell-mediated immunity are likely to be required. In this respect, naked DNA vaccines have the potential to provide high-level protection.
2010 Excerpta Medica Inc. All rights reserved.
Similar articles
-
Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.Vaccine. 2010 Jul 12;28(31):5005-11. doi: 10.1016/j.vaccine.2010.05.022. Epub 2010 May 21. Vaccine. 2010. PMID: 20546831
-
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.Vaccine. 2009 Jul 16;27(33):4447-51. doi: 10.1016/j.vaccine.2009.05.040. Epub 2009 May 31. Vaccine. 2009. PMID: 19490962
-
Melioidosis vaccines.Expert Rev Vaccines. 2002 Dec;1(4):477-82. doi: 10.1586/14760584.1.4.477. Expert Rev Vaccines. 2002. PMID: 12901586 Review.
-
Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.Southeast Asian J Trop Med Public Health. 2011 Sep;42(5):1190-6. Southeast Asian J Trop Med Public Health. 2011. PMID: 22299445
-
Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Vaccine. 2017. PMID: 28336210 Review.
Cited by
-
Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.PLoS One. 2012;7(4):e35386. doi: 10.1371/journal.pone.0035386. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530013 Free PMC article.
-
Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.PLoS Negl Trop Dis. 2012 Jan;6(1):e1488. doi: 10.1371/journal.pntd.0001488. Epub 2012 Jan 31. PLoS Negl Trop Dis. 2012. PMID: 22303489 Free PMC article.
-
Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic Burkholderia spp.mSphere. 2019 Jan 2;4(1):e00674-18. doi: 10.1128/mSphere.00674-18. mSphere. 2019. PMID: 30602525 Free PMC article.
-
Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.Mol Cell Proteomics. 2013 Nov;12(11):3036-51. doi: 10.1074/mcp.M113.029041. Epub 2013 Jun 24. Mol Cell Proteomics. 2013. PMID: 23800426 Free PMC article.
-
Consensus on the development of vaccines against naturally acquired melioidosis.Emerg Infect Dis. 2015 Jun;21(6):e141480. doi: 10.3201/eid2106.141480. Emerg Infect Dis. 2015. PMID: 25992835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources